AbCellera Biologics ABCL
NASDAQ ABCL
$13.92 +1.22 (+9.61%)
At close: Sep 28, 2026 · 4:00 PM EDT

AbCellera Biologics (ABCL) Return on Capital Employed [ROCE] (2021 - 2026)

Updated

AbCellera Biologics' Return on Capital Employed [ROCE] came in at -17.95% for Q2 2026, up 3.38 percentage points from -21.34% a year earlier but down 1.45 percentage points from the prior quarter.

Analysis

AbCellera Biologics (ABCL) Return on Capital Employed [ROCE] (2021 - 2026) Analysis & Trends

For FY2025, AbCellera Biologics' Return on Capital Employed [ROCE] was -16.77%, up 6.58 percentage points from FY2024.

  • Return on Capital Employed [ROCE] carries a four-year change of -36.40 percentage points (FY2021 to FY2025).
  • Going back by year, Return on Capital Employed [ROCE] was -23.36% in FY2024 (-6.36 pp), -17.00% in FY2023 (-33.51 pp), 16.51% in FY2022 (-3.12 pp) and 19.63% in FY2021.
  • The five-year range for quarterly Return on Capital Employed [ROCE] is -25.26% (Q1 2025) to 25.50% (Q3 2021).
  • Year-over-year, Return on Capital Employed [ROCE] has increased for four consecutive quarters, with an average year-over-year change of -0.37 percentage points over the last eight quarters.
  • The fastest year-over-year change in Return on Capital Employed [ROCE] over five years came in Q1 2026 (a gain of 8.76 percentage points), and the weakest in Q3 2023 (a drop of 37.66 percentage points).
  • Business Quant data shows ABCL's Return on Capital Employed [ROCE] at -16.50% (Q1 2026), -16.80% (Q4 2025) and -19.94% (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROCE (Qtr)
1 Johnson & Johnson 653.54 Bn 572.07 Bn 17.26 Bn 17.83%
2 AbbVie 467.01 Bn 440.17 Bn 12.70 Bn 17.92%
3 Merck 367.16 Bn 321.59 Bn 12.21 Bn 6.28%
4 Novartis Ag 277.56 Bn 233.43 Bn 11.24 Bn 19.32%
5 Astrazeneca 258.23 Bn 231.79 Bn 12.86 Bn 9.54%
6 Amgen 224.14 Bn 179.54 Bn 7.24 Bn 16.66%
7 Gilead Sciences 187.30 Bn 161.42 Bn 6.22 Bn -5.97%
8 Pfizer 163.47 Bn 110.41 Bn 10.94 Bn 11.86%
9 Vertex Pharmaceuticals 133.31 Bn 105.31 Bn 2.84 Bn 20.76%
10 AbCellera Biologics 3.89 Bn 3.89 Bn - -17.95%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -17.95%
Mar 31, 2026 -16.50%
Dec 31, 2025 -16.80%
Sep 30, 2025 -19.94%
Jun 30, 2025 -21.34%
Mar 31, 2025 -25.26%
Dec 31, 2024 -24.21%
Sep 30, 2024 -23.28%
Jun 30, 2024 -19.69%
Mar 31, 2024 -16.58%
Dec 31, 2023 -17.17%
Sep 30, 2023 -14.77%
Jun 30, 2023 -8.32%
Mar 31, 2023 -5.13%
Dec 31, 2022 15.16%
Sep 30, 2022 22.89%
Jun 30, 2022 19.68%
Mar 31, 2022 21.85%
Dec 31, 2021 18.18%
Sep 30, 2021 25.50%
API Access

AbCellera Biologics Return on Capital Employed [ROCE] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=ABCL&period=max&api_key=YOUR_API_KEY